Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KitazatoTSE:368A +0.79%22 FCF Margin % is 31.19% as of Mar. 2026, which is 6% above its 10-year median of 29.32. GuruFocus rates TSE:368A with a GF Score™ of 22/100. Among 815 Medical Devices & Instruments companies, Kitazato ranks better than 98.4% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Kitazato's Free Cash Flow for the
six
months ended in Mar. 2026 was 円1,778 Mil. Kitazato's Revenue for the
six
months ended in Mar. 2026 was 円5,700 Mil. Therefore, Kitazato's FCF Margin % for the quarter that ended in Mar. 2026 was 31.19%.
The historical rank and industry rank for Kitazato's FCF Margin % or its related term are showing as below:
TSE:368A'
s FCF Margin % Range Over the Past 10 Years
Min: 21.93 Med: 29.32 Max: 43.8
Current: 33.17
During the past 4 years, the highest FCF Margin % of Kitazato was 43.80%. The lowest was 21.93%. And the median was 29.32%.
TSE:368A's FCF Margin % is ranked better than 98.4% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.56
vs TSE:368A: 33.17
The historical data trend for Kitazato's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:368A vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Kitazato's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kitazato FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Kitazato's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Kitazato's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kitazato (TSE:368A) has a FCF Margin % of 31.19% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Kitazato and its competitors. This is near median its historical median of 29.32. Over the past decade, Kitazato's FCF Margin % has ranged from 21.93 to 43.80. According to the industry distribution chart, Kitazato ranks #13 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 1.6%.
Is Kitazato's FCF Margin % too high?
Kitazato's current FCF Margin % of 31.19% is near median its 10-year median of 29.32. Over the past 10 years, this metric has ranged from a low of 21.93 to a high of 43.80. Based on the distribution chart, Kitazato ranks #13 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Kitazato has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Kitazato's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Kitazato ranks #13 out of 815 companies for FCF Margin %. This places Kitazato in the top 2% of its industry — outperforming the majority of peers. Historically, Kitazato's own FCF Margin % has ranged from 21.93 to 43.80 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Kitazato and its competitors. Kitazato's current FCF Margin % is 31.19%, which is near median its own 10-year median of 29.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kitazato stock overvalued right now?
Kitazato (TSE:368A) has a current FCF Margin % of 31.19%. The current FCF Margin % is 31.19%, which is near median its 10-year median of 29.32. Kitazato's overall GF Score™ is 22/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Kitazato (TSE:368A), the current FCF Margin % is 31.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kitazato Corp is engaged in manufacture and sale of medical devices and related products for fertility treatment. Its products include Needles, Catheters and Cannulas, Vitrification Media and Equipments, Sperm Processing Medium/Tools, IVF Medium, etc.
22GF Score
Get the complete analysis for TSE:368A
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:368A has been successfully added to your 
